PR NEWSWIRE (EN) Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib in Moderate-to-Severe Atopic Dermatitis 2 Mac 2026, 12:00 am
PR NEWSWIRE (EN) Toku Reports US$34.8 million Revenue in FY2025 as AI Adoption Gains Traction; Underlying Loss Improves 2 Mac 2026, 12:00 am
PR NEWSWIRE (EN) Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma 2 Mac 2026, 12:00 am
PR NEWSWIRE (EN) Trip.com’s Go Explore Mega Sale Set to Launch – Save on Flights, Hotels, Tours & More 1 Mac 2026, 9:00 pm
